Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
DYRK2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
FGD4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SCRN3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
BECN1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LINC00963 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
PNMA1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TGIF1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DTYMK - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LOC101927027 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
BTF3L4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CDC16 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TAF9B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PLAGL1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PLCXD2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LRRFIP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CPEB2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PLSCR1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
AHRR - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NMT2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on